Sherif Kamal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sherif Kamal has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Adel Elamragy
Cairo University, Giza, Egypt
1 shared publication - Ahmed Bendary
Benha University, Benha, Egypt
1 shared publication - Ahmed Shawky Elserafy
Ain Shams University, Cairo, Egypt
1 shared publication - Ashraf Reda
Menoufia University, Shibīn al-Kawm, Egypt
1 shared publication - Hala Mahfouz Badran
Menoufia University, Shibin Al Kawm, Egypt
1 shared publication - Hazem Khamis
Wady El Nile Hospital, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 20 January 2026
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 78 (1) , 6
2025 Egyptian guidelines for the management of dyslipidemia
Background: The burden of premature atherosclerotic cardiovascular disease (ASCVD) in Egypt remains disproportionately high, and current international dyslipidemia guidelines have proven insufficient in achieving target lipid levels in the local population. This underscores the necessity for a context-specific national guideline. The 2025 Egyptian Guidelines for the Management of Dyslipidemia were developed through a structured consensus process led by an expert panel of cardiologists, endocrinologists, and representatives from national medical societies. Main text: The methodology included two rounds of blind voting followed by a consensus meeting to ensure rigorous evaluation. The guidelines emphasize the importance of early detection of dyslipidemia through systematic screening programs and prioritize lifestyle interventions as the cornerstone of management. A novel “extreme-risk” category was introduced to identify patients requiring intensified lipid-lowering strategies, including early initiation of combination pharmacotherapy. Additionally, the recommendations highlight the critical role of ongoing monitoring and follow-up to sustain long-term lipid control and reduce cardiovascular risk. Conclusion: The current guidelines provide a simplified, yet evidence-based framework tailored to the Egyptian population, aiming to optimize dyslipidemia management, reduce ASCVD-related complications, and improve overall cardiovascular outcomes.
- 20 January 2026
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 78 (1) , 6
Open Access2025 Egyptian guidelines for the management of dyslipidemia
Background: The burden of premature atherosclerotic cardiovascular disease (ASCVD) in Egypt remains disproportionately high, and current international dyslipidemia guidelines have proven insufficient in achieving target lipid levels in the local population. This underscores the necessity for a context-specific national guideline. The 2025 Egyptian Guidelines for the Management of Dyslipidemia were developed through a structured consensus process led by an expert panel of cardiologists, endocrinologists, and representatives from national medical societies. Main text: The methodology included two rounds of blind voting followed by a consensus meeting to ensure rigorous evaluation. The guidelines emphasize the importance of early detection of dyslipidemia through systematic screening programs and prioritize lifestyle interventions as the cornerstone of management. A novel “extreme-risk” category was introduced to identify patients requiring intensified lipid-lowering strategies, including early initiation of combination pharmacotherapy. Additionally, the recommendations highlight the critical role of ongoing monitoring and follow-up to sustain long-term lipid control and reduce cardiovascular risk. Conclusion: The current guidelines provide a simplified, yet evidence-based framework tailored to the Egyptian population, aiming to optimize dyslipidemia management, reduce ASCVD-related complications, and improve overall cardiovascular outcomes.